We did not find any statistically significant difference for sex, tumor location, tumor grading, presence of tumor infiltrating leukocyte (TIL) status, presence of signet ring appearance, CEA level, microsatellite instability (MSI), KRAS mutation, BRAF mutation, EGFR mutation, and relative telomere length (RTL) shortening. This evidence concerns the gene KRAS and neoplasm.